Skip to main content
Go to homepage

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma COG-ACNS0831

Maintenance Chemotherapy or Observation Following Induction Chemo and Radiation for Ependymoma

Description:

For complete information, please visit the study on clinicaltrials.gov

Interested in participating?
We are currently recruiting
Study Sponsor:

Children's Oncology Group

Full IRB Study Title:
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
IRB Study ID:
1110813
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program